265 related articles for article (PubMed ID: 26444110)
41. Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods.
Pace LE; Dusetzina SB; Keating NL
Med Care; 2016 Sep; 54(9):811-7. PubMed ID: 27213549
[TBL] [Abstract][Full Text] [Related]
42. Characteristics associated with interest in long-acting reversible contraception in a postpartum population.
Tang JH; Dominik R; Re S; Brody S; Stuart GS
Contraception; 2013 Jul; 88(1):52-7. PubMed ID: 23158805
[TBL] [Abstract][Full Text] [Related]
43. Factors associated with the uptake of long-acting reversible contraception among female sex workers in post-conflict Northern Uganda: a cross-sectional study.
Ouma S; Tumwesigye NM; Abbo C; Ndejjo R
Reprod Health; 2022 Feb; 19(1):34. PubMed ID: 35109873
[TBL] [Abstract][Full Text] [Related]
44. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
45. Initiation of Long-Acting Reversible Contraception in Hospitalized Adolescents in the United States.
Allison BA; Ritter V; Flower KB; Perry MF
Hosp Pediatr; 2021 Jul; 11(7):764-770. PubMed ID: 34112700
[TBL] [Abstract][Full Text] [Related]
46. Perceptions of access to long-acting reversible contraception removal among women in Burkina Faso.
Sokol NA; Sawadogo N; Bullington BW; Tumlinson K; Langer A; Soura A; Zabre P; Sie A; Johnson JA; Senderowicz L
Contraception; 2024 Jan; 129():110302. PubMed ID: 37802461
[TBL] [Abstract][Full Text] [Related]
47. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
48. Racial and ethnic differences in patterns of long-acting reversible contraceptive use in the United States, 2011-2015.
Kramer RD; Higgins JA; Godecker AL; Ehrenthal DB
Contraception; 2018 May; 97(5):399-404. PubMed ID: 29355492
[TBL] [Abstract][Full Text] [Related]
49. Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont.
Rey CN; Badger GJ; Melbostad HS; Wachtel D; Sigmon SC; MacAfee LK; Dougherty AK; Heil SH
Contraception; 2020 May; 101(5):333-337. PubMed ID: 32014521
[TBL] [Abstract][Full Text] [Related]
50. Changes in use of long-acting contraceptive methods in the United States, 2007-2009.
Finer LB; Jerman J; Kavanaugh ML
Fertil Steril; 2012 Oct; 98(4):893-7. PubMed ID: 22795639
[TBL] [Abstract][Full Text] [Related]
51. Long-acting reversible contraception and condom use: A cohort study of female adolescents and young adults in New York City.
Loh M; Niu L; Arden M; Burk RD; Diaz A; Schlecht NF
Contraception; 2023 Sep; 125():110081. PubMed ID: 37263371
[TBL] [Abstract][Full Text] [Related]
52. Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana.
Henry D; Wood S; Moshashane N; Ramontshonyana K; Amutah C; Maleki P; Howlett C; Brooks MJ; Mussa A; Joel D; Steenhoff AP; Akers AY; Morroni C
J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):504-513. PubMed ID: 33766793
[TBL] [Abstract][Full Text] [Related]
53. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
54. Use of Highly Effective Reversible Contraception in Title X Clinics: Variation by Selected State Characteristics.
Hale N; Khoury A; Smith M
Womens Health Issues; 2018; 28(4):289-296. PubMed ID: 29661696
[TBL] [Abstract][Full Text] [Related]
55. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
[TBL] [Abstract][Full Text] [Related]
56. Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women.
Moniz MH; Soliman AB; Kolenic GE; Tilea A; Fendrick AM; Bell S; Dalton VK
Womens Health Issues; 2019; 29(6):465-470. PubMed ID: 31495642
[TBL] [Abstract][Full Text] [Related]
57. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
Fleming D; Davie J; Glasier A
Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
[TBL] [Abstract][Full Text] [Related]
58. Factors that influence the choice of long-acting reversible contraceptive use among adolescents post-abortion in Chongqing, China: a cross-sectional study.
Jin F; Yang Y; Sun J; Li R; Yao F; Liu X
J Obstet Gynaecol; 2024 Dec; 44(1):2316625. PubMed ID: 38353518
[TBL] [Abstract][Full Text] [Related]
59. Predictors of long-acting reversible contraception use among unmarried young adults.
Dempsey AR; Billingsley CC; Savage AH; Korte JE
Am J Obstet Gynecol; 2012 Jun; 206(6):526.e1-5. PubMed ID: 22425402
[TBL] [Abstract][Full Text] [Related]
60. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
Secura GM; Allsworth JE; Madden T; Mullersman JL; Peipert JF
Am J Obstet Gynecol; 2010 Aug; 203(2):115.e1-7. PubMed ID: 20541171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
